Lonafarnib, sold under the brand name Zokinvy, is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in people one year of age and older. It is under trial for its use as combination treatment for Hepatitis D Virus.
via Wikipedia infobox
{{Infobox drug | drug_name = | INN = | type = | image = Lonafarnib.svg | image_class = skin-invert-image | width = 200 | alt = | caption =
| pronounce = | tradename = Zokinvy | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = Lonafarnib | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = A16 | ATC_suffix = AX20 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).